These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35501265)

  • 1. Report of a combination of remdesivir, intravenous methylprednisolone pulse, and tocilizumab for severe coronavirus disease: 20-case series at a single institution.
    Ichiyama T; Komatsu M; Wada Y; Hanaoka M
    Respir Investig; 2022 Jul; 60(4):604-606. PubMed ID: 35501265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection.
    Ye ZW; Yuan S; Chan JF; Zhang AJ; Yu CY; Ong CP; Yang D; Chan CC; Tang K; Cao J; Poon VK; Chan CC; Cai JP; Chu H; Yuen KY; Jin DY
    Emerg Microbes Infect; 2021 Dec; 10(1):291-304. PubMed ID: 33538646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Study of Use of Remdesivir and Tocilizumab in Severely Ill COVID-19 Patients.
    Gupta V; Ingawale S; Bhondve A; Khot W; Salagre S; Sonawale A; Joshi K; Vaidya M; Tiwari S; Salagre K; Pawade Y; Kawale J; Sabnis N
    J Assoc Physicians India; 2021 Jul; 69(7):14-19. PubMed ID: 34431263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment with Remdesivir and corticosteroids in a patient with COVID-19-associated pneumonia: A case report.
    Gonzales-Zamora JA; Quiroz T; Vega AD
    Medwave; 2020 Aug; 20(7):e7998. PubMed ID: 32876623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notes From the Field: The Combined Effects of Tocilizumab and Remdesivir in a Patient With Severe COVID-19 and Cytokine Release Syndrome.
    Ali S; Khalid S; Afridi M; Akhtar S; Khader YS; Akhtar H
    JMIR Public Health Surveill; 2021 May; 7(5):e27609. PubMed ID: 34009133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020.
    Rocca E; Gauffin O; Savage R; Vidlin SH; Grundmark B
    Drug Saf; 2021 Sep; 44(9):987-998. PubMed ID: 34374967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the efficacy of tocilizumab with corticosteroid therapy in treating COVID-19 patients: a systematic review and meta-analysis.
    Lim PC; Wong KL; Rajah R; Chong MF; Chow TS; Subramaniam S; Lee CY
    Daru; 2022 Jun; 30(1):211-228. PubMed ID: 35084705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients.
    Sarhan RM; Harb HS; Abou Warda AE; Salem-Bekhit MM; Shakeel F; Alzahrani SA; Madney YM; Boshra MS
    J Infect Public Health; 2022 Jan; 15(1):116-122. PubMed ID: 34764044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case Report for Severe COVID-19 in a 9-Year-Old Child Treated with Remdesivir and Dexamethasone.
    Jo YH; Hwang Y; Choi SH
    J Korean Med Sci; 2021 Jul; 36(29):e203. PubMed ID: 34313036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Stage Combination Treatment with Methylprednisolone Pulse and Remdesivir for Severe COVID-19 Pneumonia.
    Mastruzzo C; Commodari E; Grasso U; La Rosa VL; Balsamo D; Circo C; Oliveri R
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36673839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing efficacy and safety of tocilizumab and methylprednisolone in the treatment of patients with severe COVID-19.
    Abbasian L; Toroghi N; Rahmani H; Khalili H; Hasannezhad M; Ghiasvand F; Jafari S; Salehi M; Salahshour F; Azadbakhsh Kanaf Gorabi M; Alizade F; Ghaderkhani S; Nakhostin M
    Int Immunopharmacol; 2022 Jun; 107():108689. PubMed ID: 35313272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients.
    Toda M; Fujii K; Yoshifuji A; Kondo Y; Itoh K; Sekine K; Kikuchi T; Ryuzaki M
    Clin Exp Nephrol; 2022 Jan; 26(1):75-85. PubMed ID: 34436742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Drug Treatments Are Prone to Sequestration in Extracorporeal Membrane Oxygenation Circuits: An Ex Vivo Extracorporeal Membrane Oxygenation Study.
    Dhanani JA; Shekar K; Parmar D; Lipman J; Bristow D; Wallis SC; Won H; Sumi CD; Abdul-Aziz MH; Roberts JA
    ASAIO J; 2024 Jun; 70(6):546-552. PubMed ID: 38829573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial.
    Rosas IO; Diaz G; Gottlieb RL; Lobo SM; Robinson P; Hunter BD; Cavalcante AW; Overcash JS; Hanania NA; Skarbnik A; Garcia-Diaz J; Gordeev I; Carratalà J; Gordon O; Graham E; Lewin-Koh N; Tsai L; Tuckwell K; Cao H; Brainard D; Olsson JK
    Intensive Care Med; 2021 Nov; 47(11):1258-1270. PubMed ID: 34609549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocilizumab and steroid treatment in patients with COVID-19 pneumonia.
    Mikulska M; Nicolini LA; Signori A; Di Biagio A; Sepulcri C; Russo C; Dettori S; Berruti M; Sormani MP; Giacobbe DR; Vena A; De Maria A; Dentone C; Taramasso L; Mirabella M; Magnasco L; Mora S; Delfino E; Toscanini F; Balletto E; Alessandrini AI; Baldi F; Briano F; Camera M; Dodi F; Ferrazin A; Labate L; Mazzarello G; Pincino R; Portunato F; Tutino S; Barisione E; Bruzzone B; Orsi A; Schenone E; Rosseti N; Sasso E; Da Rin G; Pelosi P; Beltramini S; Giacomini M; Icardi G; Gratarola A; Bassetti M
    PLoS One; 2020; 15(8):e0237831. PubMed ID: 32817707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival benefit of remdesivir in hospitalized COVID-19 patients with high SARS-CoV-2 viral loads and low-grade systemic inflammation.
    Padilla S; Polotskaya K; Fernández M; Gonzalo-Jiménez N; de la Rica A; García JA; García-Abellán J; Mascarell P; Gutiérrez F; Masiá M
    J Antimicrob Chemother; 2022 Jul; 77(8):2257-2264. PubMed ID: 35534369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19.
    Izumo T; Kuse N; Awano N; Tone M; Sakamoto K; Takada K; Muto Y; Fujimoto K; Saiki A; Ito Y; Matsumoto H; Inomata M
    Respir Investig; 2021 Nov; 59(6):799-803. PubMed ID: 34413006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials.
    Bokharee N; Khan YH; Khokhar A; Mallhi TH; Alotaibi NH; Rasheed M
    Expert Rev Anti Infect Ther; 2021 Oct; 19(10):1219-1244. PubMed ID: 33719819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.